Endometrial cancer (EC) is the most common and lethal gynaecological cancer type in Europe and in North America. Frequently EC arises more in the corpus proper and manifests as round, polypoid expansile masses but it may also originate in the lower uterine segment or spread in endometrium with necrosis and hemorrhage. The analysis was performed using a custom panel containing all DNA sequences loci coding pre-miRNAs and genes related to biogenesis and regulation of sncRNAs in normal and tumor tissues extracted from 6 unrelated patients with endometrial carcinoma. The identified variations were correlated with mature miRNAs differentially expressed in the same normal and tumor endometrial tissues. The comparative analysis confirmed the high ...
In endometrial carcinoma, the clinical outcome directly correlates with the TNM stage, but the lack ...
Objective This study aims to reveal the regulation network of lncRNAs-miRNAs-mRNA in endometrial car...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...
Endometrial cancer (EC) is the most common and lethal gynaecological cancer type in Europe and in No...
Endometrial cancer (EC) is the most common and lethal gynaecological cancer type in Europe and in No...
A simple meta-analysis of eight microRNA (miRNA) expression surveys of endometrial cancers reveals a...
Background Endometrial cancer (EC) is the most frequently diagnosed gynecological malignancy and the...
Endometrial carcinoma (EC) is a hall mark of gynecological malignancies that usually affects women a...
Endometrial cancer is the most common gynecological cancer and the fourth most common cancer in wome...
Small non-coding RNAs (sncRNAs) represent a heterogeneous group of <200nt-long transcripts comprisin...
SummaryWe performed an integrated genomic, transcriptomic, and proteomic characterization of 373 end...
We aimed to identify endometrioid endometrial carcinoma (EEC)-related gene signatures using a multi-...
Endometrial cancer (EC) is the most common gynaecological malignancy in the western world and it com...
Endometrial intraepithelial neoplasia (EIN), also known as endometrial atypical hyperplasia (EAH) is...
Endometrial cancer is the most common gynaecological cancer in New Zealand and the incidence is incr...
In endometrial carcinoma, the clinical outcome directly correlates with the TNM stage, but the lack ...
Objective This study aims to reveal the regulation network of lncRNAs-miRNAs-mRNA in endometrial car...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...
Endometrial cancer (EC) is the most common and lethal gynaecological cancer type in Europe and in No...
Endometrial cancer (EC) is the most common and lethal gynaecological cancer type in Europe and in No...
A simple meta-analysis of eight microRNA (miRNA) expression surveys of endometrial cancers reveals a...
Background Endometrial cancer (EC) is the most frequently diagnosed gynecological malignancy and the...
Endometrial carcinoma (EC) is a hall mark of gynecological malignancies that usually affects women a...
Endometrial cancer is the most common gynecological cancer and the fourth most common cancer in wome...
Small non-coding RNAs (sncRNAs) represent a heterogeneous group of <200nt-long transcripts comprisin...
SummaryWe performed an integrated genomic, transcriptomic, and proteomic characterization of 373 end...
We aimed to identify endometrioid endometrial carcinoma (EEC)-related gene signatures using a multi-...
Endometrial cancer (EC) is the most common gynaecological malignancy in the western world and it com...
Endometrial intraepithelial neoplasia (EIN), also known as endometrial atypical hyperplasia (EAH) is...
Endometrial cancer is the most common gynaecological cancer in New Zealand and the incidence is incr...
In endometrial carcinoma, the clinical outcome directly correlates with the TNM stage, but the lack ...
Objective This study aims to reveal the regulation network of lncRNAs-miRNAs-mRNA in endometrial car...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...